Back to search

France· FR:69586398

AMINOPHYLLINE RENAUDIN 250 mg/10 ml, solution pour perfusion

A aminophylline product containing aminophylline, registered in France by LABORATOIRE RENAUDIN. The same ATC class is registered in 11 of our 19 countries.

ATC R03DA05

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedAMINOPHYLLINE RENAUDIN 250 mg/10 ml, …ATCR03DA05REGISTER NO.FR:69586398PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Aminophylline is registered in 11 of 19 countries.

Countries holding a registration under ATC R03DA05 (aminophylline), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 7 of them publish a price we can compare per daily dose

Aminophylline · ATC R03DA05

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Ireland
  • Japan
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
AMINOPHYLLINE
Manufacturer
LABORATOIRE RENAUDIN
Country
France (FR)
ATC code
R03DA05
ATC class
Aminophylline
Defined daily dose
0.6 g, O
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400956538829
    10 ampoule(s) bouteille en verre de 10 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

323 interactions on record for aminophylline.

Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Aminophylline · interactions on record

323 records

  • 34 severe
  • 174 moderate
  • 38 minor
  • 76 info

Most severe, free to view

  • MexiletineC01BB02severe
  • RiociguatC02KX05severe
  • PindololC07AA03severe
  • PropranololC07AA05severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Aminophylline in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All aminophylline products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Bulgaria · Софафилин
  • Czechia · Syntophyllin
  • Finland · Aminocont
  • United Kingdom (Northern Ireland) · Aminophylline N.A., Phyllocontin
  • Greece · Aminophylline Cooper, Αμινοφυλλινη Demo
  • Croatia · Brolyfin
  • Hungary · Diaphyllin Venosum
  • Ireland · Aminophylline Hydrate Mercury Pharmaceuticals (Ireland) Ltd, Phyllocontin
  • Italy · Aminofillina Galenica Senese, Aminofillina Monico
  • Lithuania · Aminophylline Sopharma Ad, Eufilinas
  • Latvia · Sophafyllin
  • Portugal · Aminofilina Labesfal, Filotempo
  • Romania · Aminofilină Arena, Aminofilina Bioeel
  • Sweden · Teofyllamin
  • Slovakia · Syntophyllin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c623fef8-cac0-4e9f-b2c0-e1b983421b5c
GET /v1/drugs/c623fef8-cac0-4e9f-b2c0-e1b983421b5c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "69586398",
  "date_amm": "1998-04-30",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "AMINOPHYLLINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about aminophylline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.